x
0

António Costa

  • Analysis & Opinion

António Costa's Opinion & Analysis
A complete archive of António Costa's articles, including current analysis & opinion.

Catabasis Pharmaceuticals Inc (NASDAQ:CATB) appears to have started another rally Friday, closing the trading session up 8% at 2.62 on big volume, which suggests a buying signal. We may be once again ...
ZIOPHARM Oncology Inc (NASDAQ:ZIOP) broke out of a four month sideways trend between 5.25 and 6.25 one month ago and over the last four weeks has tested the breakout area successfully on two occasions...
Contravir Pharmaceuticals Inc. (NASDAQ:CTRV) closed slightly below key resistance on volume. The technical daily chart above shows a large consolidating pennant shape that could see a strong breakout ...
IntelliPharmaCeutics International (NASDAQ:IPCI) jumped 21c, or 7.24%, on Friday to 3.11, just 22c below its 52 week high of 3.33. The stock broke its descending trend line (yellow line on chart) and ...
Put BlackBerry Ltd (NASDAQ:BBRY) on your radar next week as a possible bounce play. The 14-day RSI hit again oversold levels that have historically acted as good buying opportunities, as you can see ...
Sunworks Inc (NASDAQ:SUNW) price action finally broke out of a falling wedge pattern accompanied by a strong volume expansion, suggesting a trend reversal higher. At the same time the stock also ...
Chiasma Inc (NASDAQ:CHMA) broke out of its significant intermediate-term resistance and surged considerably higher amidst impressive buying pressure on Friday. I'm going to keep an eye on it and see ...
Apple Inc. (NASDAQ:AAPL) has been consolidating its big run from 102.53 to 116.18 earlier this month in a bull-flag formation. This is a bullish trend continuation chart pattern, indicating the ...
Minerva Neu (NASDAQ:NERV) closed at 14.31 on Friday, reconfirming the new uptrend after the recent break of the 13.75 resistance level. Because of this, I feel that this stock is ready to go towards ...
Fitbit Inc (NYSE:FIT) An intraday close above horizontal resistance $16 would bring expectations of a spike higher towards $18 followed by $18.85 (April highs). From a technical standpoint, indicators...